Safety and efficacy of bedtime versus daytime administration of the miconazole nitrate 1200 mg vaginal ovule insert to treat vulvovaginal candidiasis

Current Medical Research and Opinion

Volumn 21, Issue 1, 2005, Pages 127-134

  Barnhart, Kurt ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b Penn Fertility Care   (United States)

Author keywords

Candidiasis, vulvovaginal; Efficacy; Miconazole; Safety

Indexed keywords

MICONAZOLE NITRATE; MONISTAT 1;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST DISEASE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DYSMENORRHEA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION; INFESTATION; INJURY; INTOXICATION; LACERATION; MAJOR CLINICAL STUDY; MEDIASTINUM DISEASE; MENSTRUAL IRREGULARITY; METRORRHAGIA; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; OVARY CYST; PELVIS PAIN SYNDROME; PREMENSTRUAL SYNDROME; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RESPIRATORY TRACT DISEASE; SIDE EFFECT; SKIN DISEASE; THORAX DISEASE; UROGENITAL TRACT DISEASE; VAGINA BLEEDING; VAGINA CANDIDIASIS; VAGINA DISCHARGE; VAGINA DISEASE;

ADMINISTRATION, INTRAVAGINAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMANS; MICONAZOLE; MIDDLE AGED; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 14744275802     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904X18018     Document Type: Article

References (18)

1. Sobel JD, Faro S, Force RW, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998;178(2):203-11
2. Hurley R, De Louvois J. Candida vaginitis. Postgrad Med J 1979;55(647):645-7
3. Geiger AM, Foxman B. Risk factors for vulvovaginal candidiasis: a case-control study among university students. Epidemiology 1996;7(2):182-7
4. Horowitz BJ, Edelstein SW, Lippman L. Sexual transmission of Candida. Obstet Gynecol 1987;69(6):883-6
5. Ainsworth BE, Haskell WL, Whit MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32(Suppl 9):S498-S516
6. Ferris DG, Nyirjesy P, Sobel JD, et al. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol 2002;99(3):419-25
7. Bergman JJ, Berg AO, Schneeweiss R, Heidrich FE. Clinical comparison of microscopic and culture techniques in the diagnosis of Candida vaginitis. J Fam Pract 1984;18:549-52
8. Rothenberg RB, Simon R, Chipperfield E, Catterall RD. Efficacy of selected diagnostic tests for sexually transmitted diseases. J Am Med Assoc 1976;235:49-51
9. Schaaf VM, Perez-Stable EJ, Borchardt K. The limited value of symptoms and signs in the diagnosis of vaginal infections. Arch Intern Med 1990;150:1929-33
10. Berg AO, Heidrich FE, Fihn SD, et al. Establishing the cause of genitourinary symptoms in women in a family practice: comparison of clinical examination and comprehensive microbiology. J Am Med Assoc 1984;251:620-5
11. Reed BD, Huck W, Zazove P. Differentiation of Gardnerella vaginalis, Candida albicans, and Trichomonas vaginalis infections of the vagina. J Fam Pract 1989;28:673-9
12. Watson MC, Grimshaw JM, Bond CM, Mollison J, Ludbrook A. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). The Cochrane library, issue 4, 2001 [accessed 8/6/04]. Available at URL: http:// www.mediscope.ch/cochrane-abstracts/ ab002845.htm
13. Carson DS, Soper DE. Vulvovaginal candidiasis: review and update of over-the-counter and prescription treatments and the pharmacist's role in patient counseling. US Pharmacist 2001;(Suppl):1-15
14. Odds FC. Resistance of yeasts to azole-derivative antifungals. J Antimicrob Chemother 1993;31:463-71
15. Merkus JM. Treatment of vaginal candidiasis: orally or vaginally? J Am Acad Dermatol 1990;23:568-72
16. Demuri GP, Hostetter MK. Resistance to antifungal agents. Pediatr Clin North Am 1995;42:665-85
17. Sobel JD, Vasquez J, Lynch M, et al. Vaginitis due to Saccharomyces cerevislae: epidemiology, clinical aspects and therapy. Clin Infect Dis 1993;16:93-9
18. Barnhart K, Pretorius ES, Marunich R, Hummel A. Vaginal distribution of miconazole nitrate suspension from administration of a single vaginal insert. J Reprod Med 2004;49(2):83-8C